Form 4: Myriad Genetics Executive Receives Stock Grant
Insider Transaction (Form 4)
Dale Muzzey, Chief Scientific Officer of Myriad Genetics Inc, received 92,632 shares of common stock on November 6, 2026.
Summary
- Grant/award: acquired 92,632 Time-Based Stock Option on November 6, 2026; holds 92,632 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Dale Muzzey — Officer (Chief Scientific Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-11-06 | Grant/award | Time-Based Stock Option | 92,632 | — | — | 92,632 |
Key Dates
| Date | Description |
|---|---|
| 2026-11-06 | Grant/award (92,632 shares) |
Keywords
insider transaction, Form 4, MYGN, MYRIAD GENETICS INC, neutral, Dale Muzzey
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.